Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

NCT00285207 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia
Uterine Cervical Dysplasia

Interventions

DRUG: placebo
DRUG: A007

Sponsor

Tigris Pharmaceuticals